You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

in10018

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer Trial in Shanghai (IN10018, Albumin-Bound Paclitaxel, Gemcitabine)

Recruiting
  • Pancreatic Cancer
  • IN10018
  • +3 more
  • Shanghai, Shanghai, China
    Renji Hospital of Shanghai Jiaotong University School of Medicin
Apr 23, 2023

Ovarian Cancer Recurrent Trial in Beijing (IN10018, Placebo of IN10018, Pegylated Liposomal Doxorubicin)

Recruiting
  • Ovarian Cancer Recurrent
  • IN10018
  • +2 more
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Science and Peking Un
Aug 23, 2023

NSCLC Trial in Shanghai (IN10018, Furmonertinib)

Recruiting
  • NSCLC
  • Shanghai, China
    Shanghai Pulmonary Hospital
Aug 8, 2023

Solid Tumor Trial (IN10018, Nab-paclitaxel, Tislelizumab)

Not yet recruiting
  • Solid Tumor
  • IN10018
  • +2 more
  • (no location specified)
Aug 1, 2023

Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • IN10018
  • +3 more
  • Jinan, China
  • +2 more
Sep 10, 2023

Solid Tumor Trial in Hangzhou (D-1553, IN10018)

Not yet recruiting
  • Solid Tumor
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital, Cancer Hospital of the University of C
Aug 5, 2022

Gastric Cancer Trial in China (IN10018, Docetaxel)

Completed
  • Gastric Cancer
  • Anyang, Henan, China
  • +7 more
Nov 15, 2022

Metastatic Melanoma Trial in United States (IN10018, Cobimetinib)

Recruiting
  • Metastatic Melanoma
  • Miami, Florida
  • +4 more
Mar 29, 2022